팜젠사이언스

All filings by 팜젠사이언스 on record concern 엑세스바이오. Between 24 January 2022 and 14 October 2025, the trades on record add up to 4 filings.

On the open market, the record shows 2 purchases and 1 sale. The totals exclude 3 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2026 to date brings 1 purchase and no sales.

On 29 January 2026 came the latest disclosure, an open-market purchase in 엑세스바이오. Filings reach the DART (FSS) feed a median of 7 days after the trade. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.